Galectin-3 is a carbohydrate binding protein involved in multiple processes
including cell-cycle regulation and apoptosis, The ability of galectin-3 t
o protect cells from apoptosis is dependent upon a region of the protein kn
own as a BH-1 domain for its homology to the anti-apoptotic protein Bcl-2,
Here, we show that a monoclonal antibody (MAb) to the human tumor suppresso
r protein p16INK4A recognizes a post-translationally modified form of human
galectin-3, The modified form is detectable in only a subset of cell types
expressing galectin-3, indicating that the modification is cell-type-speci
fic. Although there is little amino acid sequence homology between p16INK4a
and galectin-3, we show by epitope mapping that the modification directly
affects the structure of galectin-3's BH-1 domain. Elucidation of the natur
e of this modification might provide further insight into galectin-3 functi
on.